跳转至内容
Merck
CN

T3379

Sigma-Aldrich

DL-酪氨酸

≥98% (TLC)

别名:

(±)-2-氨基-3-(4-羟基苯基)丙酸, 3-(4-羟基苯基)-DL-丙氨酸

登录查看公司和协议定价

选择尺寸


关于此项目

线性分子式:
4-(HO)C6H4CH2CH(NH2)COOH
化学文摘社编号:
分子量:
181.19
Beilstein:
515881
EC 号:
MDL编号:
UNSPSC代码:
12352200
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

方案

≥98% (TLC)

mp

≥300 °C (lit.)

SMILES字符串

NC(Cc1ccc(O)cc1)C(O)=O

InChI

1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)

InChI key

OUYCCCASQSFEME-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

生化/生理作用

多巴胺和其他儿茶酚胺的氨基酸前体

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

W D Phillips et al.
Experimental neurology, 270, 29-40 (2014-12-30)
Muscle-specific tyrosine kinase (MuSK) autoantibodies are the hallmark of a form of myasthenia gravis (MG) that can challenge the neurologist and the experimentalist. The clinical disease can be difficult to treat effectively. MuSK autoantibodies affect the neuromuscular junction in several
Shannon L Maude et al.
Blood, 125(11), 1759-1767 (2015-02-04)
Early T-cell precursor (ETP) acute lymphoblastic leukemia (ALL) is a recently described subtype of T-ALL characterized by a unique immunophenotype and genomic profile, as well as a high rate of induction failure. Frequent mutations in cytokine receptor and Janus kinase
Z Xiong et al.
Stem cell research, 12(2), 387-399 (2014-01-01)
An essential step for therapeutic and research applications of stem cells is their ability to differentiate into specific cell types. Neuronal cells are of great interest for medical treatment of neurodegenerative diseases and traumatic injuries of central nervous system (CNS)
Elpida Tsika et al.
Human molecular genetics, 23(17), 4621-4638 (2014-04-18)
Mutations in the vacuolar protein sorting 35 homolog (VPS35) gene at the PARK17 locus, encoding a key component of the retromer complex, were recently identified as a new cause of late-onset, autosomal dominant Parkinson's disease (PD). Here we explore the
Philippe Menasché et al.
European heart journal, 36(12), 743-750 (2014-05-20)
There is now compelling evidence that cells committed to a cardiac lineage are most effective for improving the function of infarcted hearts. This has been confirmed by our pre-clinical studies entailing transplantation of human embryonic stem cell (hESC)-derived cardiac progenitors

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持